Zhengyi Ruan
No. 639, Zhizaoju Road
Huangpu, 200011, China
Huangpu, 200011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
DC-derived CXCL10 promotes CTL activation to suppress ovarian cancer.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: October 14, 2023
Comparing Anatomical and Functional Outcomes of Two Neovaginoplasty Techniques for Mayer-Rokitansky-Küster-Hauser Syndrome: A Ten-Year Retrospective Study with Swine Small Intestinal Submucosa and Homologous Skin Grafts.
Journal: Therapeutics and clinical risk management
Published: April 04, 2023
GATA3 Encapsulated by Tumor-Associated Macrophage-Derived Extracellular Vesicles Promotes Immune Escape and Chemotherapy Resistance of Ovarian Cancer Cells by Upregulating the CD24/Siglec-10 Axis.
Journal: Molecular pharmaceutics
Published: December 22, 2022
CUL3/SPOP complex prevents immune escape and enhances chemotherapy sensitivity of ovarian cancer cells through degradation of PD-L1 protein.
Journal: Journal for immunotherapy of cancer
Published: September 07, 2022
TAM-derived extracellular vesicles containing microRNA-29a-3p explain the deterioration of ovarian cancer.
Journal: Molecular therapy. Nucleic acids
Published: October 23, 2020
Bone marrow stromal cells-derived microRNA-181-containing extracellular vesicles inhibit ovarian cancer cell chemoresistance by downregulating MEST via the Wnt/β-catenin signaling pathway.
Journal: Cancer gene therapy
Published: March 12, 2020
OCT4 accelerates tumorigenesis through activating JAK/STAT signaling in ovarian cancer side population cells.
Journal: Cancer management and research
Published: January 16, 2019
Isolation and characterization of side population cells from the human ovarian cancer cell line SK-OV-3.
Journal: Experimental and therapeutic medicine
Published: October 16, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026